(Q35210360)

7 August 2017

1 reference

title

Clinically important differences in health-related quality of life for patients with asthma: an expert consensus panel report (English)

1 reference

7 August 2017

0 references

Kathleen W Wyrwich

1

1 reference

7 August 2017

Harold S Nelson

2

1 reference

7 August 2017

William M Tierney

3

1 reference

7 August 2017

Ajit N Babu

4

1 reference

7 August 2017

Kurt Kroenke

5

1 reference

7 August 2017

Fredric D Wolinsky

6

1 reference

7 August 2017

publication date

1 August 2003

1 reference

Annals of Allergy, Asthma & Immunology

7 August 2017

published in

1 reference

7 August 2017

volume

91

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

148-153

1 reference

Measuring quality of life in asthma

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

A scale for the measurement of quality of life in adults with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

A scale for assessing quality of life in adult asthma sufferers.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

The development of the 'Quality-of-life for Respiratory Illness Questionnaire (QOL-RIQ)': a disease-specific quality-of-life questionnaire for patients with mild to moderate chronic non-specific lung disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

The effect of inhaled albuterol in moderate to severe asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

Nocturnal asthma: effect of salmeterol on quality of life and clinical outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

The sickness impact profile: conceptual formulation and methodology for the development of a health status measure

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

Fluticasone propionate improves quality of life in patients with asthma requiring oral corticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

Emergency Department Observation Unit versus hospital inpatient care for a chronic asthmatic population: a randomized trial of health status outcome and cost

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

Clinical predictors of health-related quality of life depend on asthma severity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

A method for the detailed assessment of the appropriateness of medical technologies

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

Format and conduct of consensus development conferences. Multi-nation comparison

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

Using the standard error of measurement to identify important changes on the Asthma Quality of Life Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962169-2

7 January 2021

10.1016/S1081-1206(10)62169-2

Identifiers

DOI

1 reference

7 August 2017

1 reference